152 related articles for article (PubMed ID: 20652816)
21. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions.
McAllister IL; Vijayasekaran S; Yu DY
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4910-8. PubMed ID: 23766477
[TBL] [Abstract][Full Text] [Related]
23. Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.
Navarro-Partida J; Altamirano-Vallejo JC; Lopez-Naranjo EJ; Gonzalez-De la Rosa A; Manzano-Ramírez A; Apatiga-Castro LM; Armendáriz-Borunda J; Santos A
J Ocul Pharmacol Ther; 2020; 36(6):393-403. PubMed ID: 32564664
[No Abstract] [Full Text] [Related]
24. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
25. Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
Kunikata H; Shimura M; Nakazawa T; Sonoda KH; Yoshimura T; Ishibashi T; Nishida K
Acta Ophthalmol; 2012 Mar; 90(2):162-7. PubMed ID: 20456252
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Kola M; Hacioglu D; Turk A; Erdol H
Cutan Ocul Toxicol; 2016 Sep; 35(3):185-9. PubMed ID: 26340259
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
Hou J; Tao Y; Jiang YR; Li XX; Gao L
Chin Med J (Engl); 2009 Nov; 122(22):2695-9. PubMed ID: 19951598
[TBL] [Abstract][Full Text] [Related]
28. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.
Ehrlich R; Ciulla TA; Moss AM; Harris A
Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):375-80. PubMed ID: 19898827
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
Retina; 2005; 25(7):851-5. PubMed ID: 16205563
[TBL] [Abstract][Full Text] [Related]
33. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion.
Zhang S; An N; Ha W; Zhang S; Hu X; Ma A; Zhao B
J Int Med Res; 2016 Jun; 44(3):685-97. PubMed ID: 26936966
[TBL] [Abstract][Full Text] [Related]
34. Different dosages of intravitreal triamcinolone acetonide injections for macular edema secondary to central retinal vein occlusion.
Wei Y; Wang H; Chen F; Zu Z; Bi C; Yang X
Eye Sci; 2012 Sep; 27(3):152-7. PubMed ID: 22993062
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O
Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781
[TBL] [Abstract][Full Text] [Related]
36. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
Kim JY; Park SP
Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.
Lee GH; Ahn JK; Park YG
Am J Ophthalmol; 2008 Jun; 145(6):1037-1044. PubMed ID: 18378211
[TBL] [Abstract][Full Text] [Related]
40. SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.
Scott IU; Blodi BA; Ip MS; Vanveldhuisen PC; Oden NL; Chan CK; Gonzalez V;
Ophthalmology; 2009 Apr; 116(4):756-61. PubMed ID: 19344824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
